FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Philippe Morlat

Research Profile

Disorders

Procedures

Living Beings

HIV-1

Geographic Areas

France

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Lene Ryom; Colette Smith; Signe W Worm; Christoph A Fux; David A Kamara; Ole Kirk; Jens D Lundgren; Amanda Mocroft; Olivier Moranne; Philippe Morlat; Peter Reiss; Michael Ross
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.
Helen Kovari; bruno ledergerber; Jens D Lundgren; Philippe Morlat; Kathy Petoumenos; Andrew Phillips; Peter Reiss; Lene Ryom; Caroline A Sabin; Colette Smith; Stéphane De Wit; Eric Fontas; Signe W Worm; Rainer Weber
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study.
Fabrice Bonnet; Mathias Bruyand; Gwenaelle Catheline; Geneviève Chêne; Francois Dabis; Jean-François Dartigues; Frédéric-Antoine Dauchy; Patrick Dehail; Carine Greib; Fabienne Marquant; Patrick Mercié; Philippe Morlat; Didier Neau; Laura Richert; Hélène Amieva; Charlotte Bernard
Cognitive disorders in HIV-infected patients: are they HIV-related?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Philippe Morlat (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lene Ryom; Colette Smith; Signe W Worm; Christoph A Fux; David A Kamara; Ole Kirk; Jens D Lundgren; Amanda Mocroft; Olivier Moranne; Philippe Morlat; Peter Reiss; Michael Ross
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.
The Journal of infectious diseases 2013;207(9):1359-69.
2013: Helen Kovari; bruno ledergerber; Jens D Lundgren; Philippe Morlat; Kathy Petoumenos; Andrew Phillips; Peter Reiss; Lene Ryom; Caroline A Sabin; Colette Smith; Stéphane De Wit; Eric Fontas; Signe W Worm; Rainer Weber
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(6):870-9.
2013: Fabrice Bonnet; Mathias Bruyand; Gwenaelle Catheline; Geneviève Chêne; Francois Dabis; Jean-François Dartigues; Frédéric-Antoine Dauchy; Patrick Dehail; Carine Greib; Fabienne Marquant; Patrick Mercié; Philippe Morlat; Didier Neau; Laura Richert; Hélène Amieva; Charlotte Bernard
Cognitive disorders in HIV-infected patients: are they HIV-related?
AIDS (London, England) 2013;27(3):391-400.
2012: Yves Lévy; Jean-Michel Molina; Philippe Morlat; Béatrice Poirier; Christine Rouzioux; Daniel Sereni; Irini Sereti; Rodolphe Thiébaut; Alain Venet; Jean-Paul Viard; Laurence Weiss; Céline Boucherie; Geneviève Chêne; Jean-François Delfraissy; Pierre-Marie Girard; Marie-Lise Gougeon; Cliff Lane; Anne-Sophie Lascaux
Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV.
AIDS (London, England) 2012;26(6):711-20.
2012: Pierre Frange; Jade Ghosn; Pierre-Marie Girard; Cecile Goujard; Laurence Meyer; Philippe Morlat; Christine Rouzioux; Laurent Tran; Marie-Laure Chaix; Christiane Deveau
Recent HIV-1 infection contributes to the viral diffusion over the French territory with a recent increasing frequency.
PloS one 2012;7(2):e31695.
2011: Marie-Anne Vandenhende; Philippe Morlat; Fabrice Bentaberry; Fabrice Bonnet
Anakinra: an effective treatment in the Schnitzler syndrome.
Joint, bone, spine : revue du rhumatisme 2011;78(6):636-7.
2011: Mathias Bruyand; Geneviève Chêne; François Dabis; Stéphane Geffard; Estibaliz Lazaro; Olivier Leleux; Philippe Morlat; Didier Neau; Marie-Anne Vandenhende; Fabrice Bonnet
HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008.
Journal of hepatology 2011;55(5):1058-62.
2011: Marc-Arthur Loko; Philippe Morlat; Didier Neau; D Salmon; L Serfaty; Maria Winnock; F Bani-Sadr; P Carrieri; François Dabis; K Lacombe
Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.
Journal of viral hepatitis 2011;18(7):e307-14.
2011: M de Pommerol; M Hessamfar; Sylvie Lawson-Ayayi; Didier Neau; S Geffard; S Farbos; B Uwamaliya; M-A Vandenhende; Jean-Luc Pellegrin; S Blancpain; François Dabis; Philippe Morlat
Menopause and HIV infection: age at onset and associated factors, ANRS CO3 Aquitaine cohort.
International journal of STD & AIDS 2011;22(2):67-72.
2011: Sami Kolta; Philippe Flandre; Philippe Ngo Van; Isabelle Cohen-Codar; Marc-Antoine Valantin; Claire Pintado; Philippe Morlat; Francois Boué; Richard Rode; Michael Norton; Brygida Knysz; Karine Briot; Christian Roux; Jean-François Delfraissy
Fat tissue distribution changes in HIV-infected patients treated with lopinavir/ritonavir. Results of the MONARK trial.
Current HIV research 2011;9(1):31-9.
2011: Sébastien Gallien; Valérie Journot; Willy Rozenbaum; Patrick Yéni; Philippe Morlat; Isabelle Poizot-Martin; Jacques Reynes; Véronique Reliquet; Pascale Leclercq; François SIMON; Geneviève Chêne; Jean-Michel Molina
Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial).
The Journal of antimicrobial chemotherapy 2011;66(1):184-91.
2010: Lionel Piroth; Stanislas Pol; Karine Lacombe; Patrick Miailhes; Agathe Rami; David Rey; Veronique Loustau-Ratti; Philippe Morlat; Isabelle Goderel; Damien Sene; Eric Rosenthal; Fabrice CARRAT; Patrice Cacoub
Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study.
Journal of hepatology 2010;53(6):1006-12.
2010: Thomas Boulet; Juliette Pavie; Isabelle Charreau; Joséphine Braun; Jacques Reynes; Philippe Morlat; Lionel Piroth; Bruno Spire; Jean-Michel Molina; Jean-Pierre Aboulker
Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138).
HIV clinical trials 2010;11(5):283-93.
2010: Daniel da Silva; Liesbeth Van Wesenbeeck; Dominique Breilh; Sandrine Reigadas; Guerric Anies; Kurt Van Baelen; Philippe Morlat; Didier Neau; Michel Dupon; Linda Wittkop; Hervé Fleury; Bernard Masquelier
HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens.
The Journal of antimicrobial chemotherapy 2010;65(6):1262-9.
2010: E K Déti; Rodolphe Thiébaut; Fabrice Bonnet; Sylvie Lawson-Ayayi; Michel Dupon; Didier Neau; Jean-Luc Pellegrin; Denis Malvy; S Tchamgoué; François Dabis; Philippe Morlat
Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France.
HIV medicine 2010;11(5):308-17.
2010: Mojgan Hessamfar-Bonarek; Philippe Morlat; Dominique Salmon; Patrice Cacoub; thierry may; Fabrice Bonnet; Eric Rosenthal; Dominique Costagliola; Charlotte Lewden; Geneviève Chêne
Causes of death in HIV-infected women: persistent role of AIDS. The 'Mortalité 2000 & 2005' Surveys (ANRS EN19).
International journal of epidemiology 2010;39(1):135-46.
2010: Christian Michaux; Philippe Morlat; Fabrice Bonnet
[Cytomegalovirus and other herpes virus infections in systemic diseases].
Presse médicale (Paris, France : 1983) 2010;39(1):34-41.
2009: Marie-Anne Bouldouyre; Isabelle Charreau; Bruno Marchou; Philippe Tangre; Christine Katlama; Philippe Morlat; Vincent Meiffredy; Daniel Vittecoq; Philippe Bierling; Jean-Pierre Aboulker; Jean-Michel Molina
Incidence and risk factors of thrombocytopenia in patients receiving intermittent antiretroviral therapy: a substudy of the ANRS 106-window trial.
Journal of acquired immune deficiency syndromes (1999) 2009;52(5):531-7.
2009: Mathias Bruyand; Rodolphe Thiébaut; Sylvie Lawson-Ayayi; Pierre Joly; Annie Jeanne Sasco; Patrick Mercié; Jean Luc Pellegrin; Didier Neau; François Dabis; Philippe Morlat; Geneviève Chêne; Fabrice Bonnet
Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(7):1109-16.
2009: Eric Rosenthal; D Salmon-Céron; Charlotte Lewden; V Bouteloup; G Pialoux; Fabrice Bonnet; M Karmochkine; thierry may; M François; Christine Burty; Eric Jougla; Dominique Costagliola; Philippe Morlat; Geneviève Chêne; Patrice Cacoub
Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19).
HIV medicine 2009;10(5):282-9.
2009: Dominique Salmon-Ceron; Eric Rosenthal; Charlotte Lewden; Vincent Bouteloup; thierry may; Christine Burty; Fabrice Bonnet; Dominique Costagliola; Eric Jougla; Caroline Semaille; Philippe Morlat; Patrice Cacoub; Geneviève Chêne
Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study.
Journal of hepatology 2009;50(4):736-45.
2009: Fabrice Bonnet; Christine Burty; Charlotte Lewden; Dominique Costagliola; thierry may; Vincent Bouteloup; Eric Rosenthal; Eric Jougla; Patrice Cacoub; Dominique Salmon; Geneviève Chêne; Philippe Morlat
Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(5):633-9.
2009: Patricia Recordon-Pinson; Guerric Anies; Mathias Bruyand; Didier Neau; Philippe Morlat; Jean-Luc Pellegrin; Alexis Groppi; Rodolphe Thiébaut; François Dabis; Hervé Fleury; Bernard Masquelier
HIV type-1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversity.
Antiviral therapy 2009;14(4):551-6.
2009: N Foucher; B Lahille; Noëlle Bernard; S Poutrel; S Pedebosq; F Bonnet; Philippe Morlat; Jean-Paul Pometan
[Influence of hospitalisation on the elderly people polypharmacy].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2009;30(1):20-4.
2008: Charlotte Lewden; Geneviève Chêne; Philippe Morlat; François Raffi; François Dabis; Catherine Leport
[Mortality rate of HIV-infected adults compared with the general population: long-term and CD4-lymphocyte-dependent results].
Médecine sciences : M/S 2008;24(10):804-6.
2008: Charlotte Lewden; thierry may; Eric Rosenthal; Christine Burty; Fabrice Bonnet; Dominique Costagliola; Eric Jougla; Caroline Semaille; Philippe Morlat; Dominique Salmon; Patrice Cacoub; Geneviève Chêne
Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).
Journal of acquired immune deficiency syndromes (1999) 2008;48(5):590-8.
2008: Olivia Peuchant; Rodolphe Thiébaut; Sophie Capdepont; Valérie Lavignolle-Aurillac; Didier Neau; Philippe Morlat; François Dabis; Hervé Fleury; Bernard Masquelier
Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
AIDS (London, England) 2008;22(12):1417-23.
2008: Charles Cazanave; Michel Dupon; Valérie Lavignolle-Aurillac; Nicole Barthe; Sylvie Lawson-Ayayi; Nadia Mehsen; Patrick Mercié; Philippe Morlat; Rodolphe Thiébaut; François Dabis
Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
AIDS (London, England) 2008;22(3):395-402.
2007: Fabrice Bonnet; Geneviève Chêne; Rodolphe Thiébaut; Michel Dupon; Sylvie Lawson-Ayayi; Jean-Luc Pellegrin; François Dabis; Philippe Morlat
Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004.
HIV medicine 2007;8(8):547-54.
2007: N Foucher; M-C Pertusa; B Lahille; Noëlle Bernard; I Louis; Mojgan Bonarek; Philippe Morlat; Jean-Paul Pometan
[Incidence and reasons of premature discontinuation of abacavir: results of a hospital investigation among 628 patients].
Médecine et maladies infectieuses 2007;37(10):684-7.
2007: Charlotte Lewden; Geneviève Chene; Philippe Morlat; François Raffi; Michel Dupon; Pierre Dellamonica; Jean-Luc Pellegrin; Christine Katlama; François Dabis; Catherine Leport
HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.
Journal of acquired immune deficiency syndromes (1999) 2007;46(1):72-7.
2007: Jean-Michel Molina; Valérie Journot; André Furco; Pierre Palmer; Nathalie de Castro; François Raffi; Philippe Morlat; thierry may; Corinne Rancinan; Geneviève Chêne
Five-year follow up of once-daily therapy with emtricitabine, didanosine and efavirenz (Montana ANRS 091 trial).
Antiviral therapy 2007;12(3):417-22.
2007: Fabrice Bonnet; Valérie Aurillac-Lavignolle; Dominique Breilh; Rodolphe Thiébaut; Evelyne Peuchant; Noëlle Bernard; Denis Lacoste; François Dabis; Jacques Beylot; Geneviève Chêne; Philippe Morlat
Pravastatin in HIV-infected patients treated with protease inhibitors: a placebo-controlled randomized study.
HIV clinical trials 2007;8(1):53-60.
2006: A Kharchafi; Philippe Morlat; P-H Bernard; Noëlle Bernard; C Balabaud; Jacques Beylot
[Hepatitis C-autoimmune hepatitis overlap syndrome: five new cases].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2006;27(12):916-23.
2006: Charlotte Lewden; Eric Jougla; A Alioum; Gérard Pavillon; L Lièvre; Philippe Morlat; Dominique Salmon; thierry may; Geneviève Chêne; Dominique Costagliola
Number of deaths among HIV-infected adults in France in 2000, three-source capture-recapture estimation.
Epidemiology and infection 2006;134(6):1345-52.
2006: Fabrice Bonnet; Anne-Christine Jouvencel; Marie Parrens; Magali Joblon Leon; Emmanuelle Cotto; Isabelle Garrigue; Philippe Morlat; Jacques Beylot; Hervé Fleury; Marie-Edith Lafon
A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(4):258-63.
2006: C Cazanave; S Rakotondravelo; Philippe Morlat; Patrick Blanco; Fabrice Bonnet; Jacques Beylot
[Autoimmune hepatitis in a HIV-HCV co-infected patient: diagnostic ant therapeutic difficulties].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2006;27(5):414-9.
2006: Sophie Capdepont; Valérie Aurillac-Lavignolle; Muriel Faure; Michel Dupon; Philippe Morlat; Jean-Marie Ragnaud; Geneviève Chêne; Hervé Fleury; Bernard Masquelier
An additive/subtractive genotypic score as a determinant of the virological response to didanosine in HIV-1 infected patients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(1):36-42.
2006: Cécile Goujard; Mojgan Bonarek; Laurence Meyer; Fabrice Bonnet; Marie-Laure Chaix; Christiane Deveau; Martine Sinet; Julie Galimand; Jean-François Delfraissy; Alain Venet; Christine Rouzioux; Philippe Morlat
CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(5):709-15.
2006: Fabrice Bonnet; Philippe Morlat
[Cancer and HIV infection: any association?].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2006;27(3):227-35.
2006: Fabrice Bonnet; Eric Balestre; Rodolphe Thiébaut; Philippe Morlat; Jean-Luc Pellegrin; Didier Neau; François Dabis
Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(3):411-7.
2005: M A Vandenhende; Fabrice Bonnet; L Sailler; S Bouillot; Philippe Morlat; Jacques Beylot
[Dilated cardiomyopathy and lipid-lowering drug muscle toxicity revealing late-onset Becker's disease].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2005;26(12):977-9.
2005: Patrick Mercié; Rodolphe Thiébaut; Valérie Aurillac-Lavignolle; Jean-Luc Pellegrin; M C Yvorra-Vives; Claire Cipriano; Didier Neau; Philippe Morlat; Jean-Marie Ragnaud; Michel Dupon; Fabrice Bonnet; Sylvie Lawson-Ayayi; Denis Malvy; R Roudaut; François Dabis
Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients.
HIV medicine 2005;6(6):380-7.
2005: RM Ramanampamonjy; L S Ramarozatovo; Fabrice Bonnet; Denis Lacoste; J Rambeloarisoa; Noëlle Bernard; Jacques Beylot; Philippe Morlat
[Portal vein thrombosis in HIV-infected patients: report of four cases].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2005;26(7):545-8.
2005: Dominique Salmon-Ceron; Charlotte Lewden; Philippe Morlat; Sibylle Bévilacqua; Eric Jougla; Fabrice Bonnet; Laurence Héripret; Dominique Costagliola; thierry may; Geneviève Chêne
Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.
Journal of hepatology 2005;42(6):799-805.
2005: M Seydi; Philippe Morlat; Fabrice Bonnet; J Rambeloarisoa; Noëlle Bernard; Denis Lacoste; Mojgan Bonarek; Pascale Trimoulet; RM Ramanampamonjy; Marie-Edith Lafon; Moustapha Dramé; Jacques Beylot
[Efficacy and safety of pegylated-interferon plus ribavirin in HIV-infected patients co-infected with hepatitis C virus in clinical practice: a 32 cases observational follow-up].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2005;26(4):280-7.
2005: Jean-Michel Molina; Valérie Journot; Laurence Morand-Joubert; Patrick Yéni; Willy Rozenbaum; Corinne Rancinan; Sandra Fournier; Philippe Morlat; Pierre Palmer; Bertrand Dupont; Cécile Goujard; Pierre Dellamonica; Fidéline Collin; Isabelle Poizot-Martin; Geneviève Chene
Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial.
The Journal of infectious diseases 2005;191(6):830-9.
2005: Charlotte Lewden; Dominique Salmon; Philippe Morlat; Sibylle Bévilacqua; Eric Jougla; Fabrice Bonnet; Laurence Héripret; Dominique Costagliola; thierry may; Geneviève Chêne
Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.
International journal of epidemiology 2005;34(1):121-30.
2005: Fabrice Bonnet; Charlotte Lewden; thierry may; Laurence Heripret; Eric Jougla; Sibylle Bevilacqua; Dominique Costagliola; Dominique Salmon; Geneviève Chêne; Philippe Morlat
Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France.
Scandinavian journal of infectious diseases 2005;37(6-7):482-7.
2004: thierry may; Charlotte Lewden; F Bonnet; Laurence Heripret; Sibylle Bevilacqua; Eric Jougla; Dominique Costagliola; Philippe Morlat; Dominique Salmon; Geneviève Chêne
[Causes and characteristics of death among HIV-1 infected patients with immunovirologic response to antiretroviral treatment].
Presse médicale (Paris, France : 1983) 2004;33(21):1487-92.
2004: Fabrice Bonnet; S Debruxelles; L Dubourguet; V Guérin; J Rambeloarisoa; Philippe Morlat; Jean-Claude Baste; Jacques Beylot
[Lupus anticoagulant and Behçet's disease: increase of vascular risk?].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2004;25(11):835-6.
2004: Xavier Duval; Valérie Journot; Catherine Leport; Geneviève Chêne; Michel Dupon; Lise Cuzin; thierry may; Philippe Morlat; Anne Waldner; Roger Salamon; François Raffi
Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(2):248-55.
2004: Fabrice Bonnet; Charlotte Lewden; thierry may; Laurence Heripret; Eric Jougla; Sibylle Bevilacqua; Dominique Costagliola; Dominique Salmon; Geneviève Chêne; Philippe Morlat
Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Cancer 2004;101(2):317-24.
2004: Charlotte Lewden; Milko Sobesky; André Cabié; Pierre Couppié; F Boulard; François Bissuel; thierry may; Philippe Morlat; Geneviève Chêne; Isabelle Lamaury; Dominique Salmon
[Causes of death among HIV infected adults in French Guyana and the French West Indies in the era of highly active antiretroviral therapy (HAART)].
Médecine et maladies infectieuses 2004;34(7):286-92.
2004: Fabrice Bonnet; Eric Balestre; Rodolphe Thiébaut; Patrick Mercié; Michel Dupon; Philippe Morlat; François Dabis
Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999-2001.
HIV medicine 2004;5(3):133-9.
2003: Damien Barcat; Viviane Guérin; A Ryman; Joël Constans; J P Vernhes; Christine Vergnes; Fabrice Bonnet; Xavier Delbrel; Philippe Morlat; M Longy-Boursier; Claude Conri
Thrombophilia and thrombosis in systemic lupus erythematosus: a case-control study.
Annals of the rheumatic diseases 2003;62(10):1016-7.
2003: Fabrice Bonnet; Jean-Jacques Pineau; Jean-Luc Taupin; Anne Feyler; Mojgan Bonarek; Sten de Witte; Noëlle Bernard; Denis Lacoste; Philippe Morlat; Jacques Beylot
Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients.
The Journal of rheumatology 2003;30(9):2005-10.
2003: Didier Neau; Anne-Christine Jouvencel; Elisabeth Legrand; Pascale Trimoulet; Tatiana Galperine; Isabelle Chitty; Michel Ventura; Brigitte Le Bail; Philippe Morlat; Jean-Yves Lacut; Jean-Marie Ragnaud; Michel Dupon; Hervé Fleury; Marie-Edith Lafon
Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients.
Journal of medical virology 2003;71(1):41-8.
2003: Eric Rosenthal; Marilyne Poirée; Christian Pradier; Christian Perronne; Dominique Salmon-Ceron; Loic Geffray; Robert P Myers; Philippe Morlat; Gilles Pialoux; Stanislas Pol; Patrice Cacoub
Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).
AIDS (London, England) 2003;17(12):1803-9.
2003: Rodolphe Thiébaut; Geneviève Chêne; Hélène Jacqmin-Gadda; Philippe Morlat; Patrick Mercié; Michel Dupon; Didier Neau; Hanta Ramaroson; François Dabis; Roger Salamon
Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001.
Journal of acquired immune deficiency syndromes (1999) 2003;33(3):380-6.
2003: Fabrice Bonnet; Mojgan Bonarek; Philippe Morlat; Patrick Mercié; Michel Dupon; M C Gemain; Denis Malvy; Noëlle Bernard; J L Pellegrin; Jacques Beylot
Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(10):1324-8.
2003: Dominique Salmon-Céron; Régis Lassalle; Alain Pruvost; Henri BENECH; Magali Bouvier-Alias; Christopher Payan; Cécile Goujard; Eric Bonnet; Fabien Zoulim; Philippe Morlat; Philippe Sogni; Sophie Pérusat; Jean-Marc Tréluyer; Geneviève Chêne
Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(10):1295-304.
2003: Rodolphe Thiébaut; Hélène Jacqmin-Gadda; Catherine Leport; Christine Katlama; Dominique Costagliola; Vincent Le Moing; Philippe Morlat; Geneviève Chêne
Bivariate longitudinal model for the analysis of the evolution of HIV RNA and CD4 cell count in HIV infection taking into account left censoring of HIV RNA measures.
Journal of biopharmaceutical statistics 2003;13(2):271-82.
2003: Sten de Witte; Fabrice Bonnet; Philippe Morlat; Jacques Beylot
Rhabdomyolysis as a consequence of adrenal insufficiency.
The American journal of medicine 2003;114(2):160.
2003: Fabrice Bonnet; Mojgan Bonarek; A Abridj; Patrick Mercié; Michel Dupon; M-C Gemain; Denis Malvy; Noëlle Bernard; J-L Pellegrin; Philippe Morlat; Jacques Beylot
[Severe lactic acidosis in HIV-infected patients treated with nucleosidic reverse transcriptase analogs: a report of 9 cases].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2003;24(1):11-6.
2003: Fabrice Bonnet; Philippe Morlat; Sten de Witte; Christian Combe; Jacques Beylot
Lupus-like syndrome and vasculitis induced by valpromide.
The Journal of rheumatology 2003;30(1):208-9.
2002: Fabrice Bonnet; Sylvie Lawson-Ayayi; Rodolphe Thiébaut; RM Ramanampamonjy; Denis Lacoste; Noëlle Bernard; Denis Malvy; Mojgan Bonarek; Félix Djossou; Jacques Beylot; François Dabis; Philippe Morlat
A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(10):1231-7.
2002: Charlotte Lewden; Fabrice Bonnet; Sibylle Bevilacqua; Laurence Heripret; thierry may; Philippe Morlat; Eric Jougla; François Dabis; Geneviève Chêne; Dominique Salmon
[Causes of death in HIV-infected French drug users, 1995-2000].
Annales de médecine interne 2002;153(7 Suppl):2S4-10.
2002: Fabrice Bonnet; Mojgan Bonarek; Sten de Witte; Jacques Beylot; Philippe Morlat
Efavirenz-associated severe hyperlipidemia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(6):776-7.
2002: Bernard Masquelier; Dominique Breilh; Didier Neau; Sylvie Lawson-Ayayi; Valérie Lavignolle; Jean-Marie Ragnaud; Michel Dupon; Philippe Morlat; François Dabis; Hervé Fleury
Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2002;46(9):2926-32.
2002: Isabelle Pellegrin; Dominique Breilh; François Montestruc; Anne Caumont; Isabelle Garrigue; Philippe Morlat; Cécile Le Camus; Marie-Claude Saux; Hervé J Fleury; Jean-Luc Pellegrin
Virologic response to nelfinavir-based regimens: pharmacokinetics and drug resistance mutations (VIRAPHAR study).
AIDS (London, England) 2002;16(10):1331-40.
2002: Fabrice Bonnet; Philippe Morlat; G Chêne; Patrick Mercié; Didier Neau; I Chossat; M Decoin; Félix Djossou; Jacques Beylot; François Dabis
Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999.
HIV medicine 2002;3(3):195-9.
2002: Sten de Witte; Fabrice Bonnet; Mojgan Bonarek; Paul Lamarque; Philippe Morlat; Marie-Catherine Receveur; Jacques Beylot
Adhesive capsulitis of the shoulder in an HIV patient treated with nelfinavir.
AIDS (London, England) 2002;16(9):1307-8.
2002: Fabrice Bonnet; Mojgan Bonarek; A Abrij; Jacques Beylot; Philippe Morlat
Metabolic acidosis in HIV-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(9):1289-90.
2002: Keith Chirgwin; Richard Hafner; Catherine Leport; Jack Remington; Janet Andersen; Elizabeth M Bosler; Clemente Roque; natasa rajicic; Vincent McAuliffe; Philippe Morlat; Dushyantha Jayaweera; Jean-Louis Vilde; Benjamin J Luft
Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(9):1243-50.
2002: Fabrice Bonnet; Philippe Morlat; J Dubuc; Sten de Witte; Mojgan Bonarek; Noëlle Bernard; Denis Lacoste; Jacques Beylot
Sarcoidosis-associated hepatitis C virus infection.
Digestive diseases and sciences 2002;47(4):794-6.
2002: Fabrice Bonnet; Marianne Savès; Philippe Morlat; C Droz; Geneviève Chêne; Evelyne Peuchant; Noëlle Bernard; Denis Lacoste; Roger Salamon; Jacques Beylot
Correlations of soluble interleukin-2 and tumor necrosis factor type II receptors with immunologic and virologic responses under HAART.
Journal of clinical immunology 2002;22(2):75-82.
2002: Geneviève Chêne; Emmanuelle Angelini; Laurent Cotte; Jean-Marie Lang; Philippe Morlat; Corinne Rancinan; thierry may; Valérie Journot; François Raffi; Bernard Jarrousse; Michèle Grappin; Gérard Lepeu; Jean-Michel Molina
Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(5):649-57.
2002: Patrick Mercié; Rodolphe Thiébaut; Valérie Lavignolle; Jean-Luc Pellegrin; Marie-Christine Yvorra-Vives; Philippe Morlat; Jean-Marie Ragnaud; Michel Dupon; Denis Malvy; Hélène Bellet; Sylvie Lawson-Ayayi; Raymond Roudaut; Françios Dabis
Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement.
Annals of medicine 2002;34(1):55-63.
2001: Joël Constans; M L Nelzy; L Rachid Salmi; Sophie Skopinski; J C Saby; P Le Métayer; Philippe Morlat; Claude Conri
Clinical prediction of lower limb deep vein thrombosis in symptomatic hospitalized patients.
Thrombosis and haemostasis 2001;86(4):985-90.
2001: Fabrice Bonnet; Philippe Morlat; Sten de Witte; Noëlle Bernard; Denis Lacoste; Jacques Beylot
[Hemorrhagic accidents with low molecular weight heparin: 15 cases].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2001;22(8):761-3.
2001: Fabrice Bonnet; J Dubuc; Philippe Morlat; Xavier Delbrel; M S Doutre; Sten de Witte; Noëlle Bernard; Denis Lacoste; Maïté Longy-Boursier; Jacques Beylot
[Sarcoidosis and comorbidity: retrospective study of 32 cases].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2001;22(7):619-23.
2001: Fabrice Bonnet; Didier Neau; Jean-François Viallard; Philippe Morlat; JM Ragnaud; Michel Dupon; P Legendre; Y Imbert; François Lifermann; Michel Le Bras; Jacques Beylot; Maïté Longy-Boursier
Clinical and laboratory findings of cytomegalovirus infection in 115 hospitalized non-immunocompromised adults.
Annales de médecine interne 2001;152(4):227-35.
2001: Catherine Marimoutou; Geneviève Chêne; Patrick Mercié; Didier Neau; S Farbos; Philippe Morlat; J Ceccaldi; François Dabis
Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998.
Journal of acquired immune deficiency syndromes (1999) 2001;27(2):161-7.
2001: Marianne Savès; Philippe Morlat; Geneviève Chêne; Evelyne Peuchant; Isabelle Pellegrin; Fabrice Bonnet; Noëlle Bernard; Denis Lacoste; Roger Salamon; Jacques Beylot
Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy.
Clinical immunology (Orlando, Fla.) 2001;99(3):347-52.
2001: Fabrice Bonnet; Marianne Savès; C Droz; Evelyne Peuchant; Geneviève Chêne; Jacques Beylot; Philippe Morlat
Increase of lipid plasma concentrations under protease inhibitor-containing regimens are not related to modifications of the tumour necrosis factor system.
AIDS (London, England) 2001;15(7):940-1.
2001: Catherine Leport; Jacqueline Franck; Geneviève Chene; F Derouin; J L Ecobichon; Sophie Pueyo; J M Miro; Benjamin J Luft; Philippe Morlat; Henri Dumon
Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virus.
Clinical and diagnostic laboratory immunology 2001;8(3):579-84.
2001: C Nouts; Mojgan Bonarek; Philippe Morlat; I Delevaux; F Bonnet; Denis Lacoste; N Bernard; J Beylot
The absence of hyperbilirubinaemia is highly predictive of treatment failure in advanced HIV-infected patients treated with indinavir.
International journal of STD & AIDS 2001;12(1):29-33.
2000: Rodolphe Thiébaut; V Daucourt; Patrick Mercié; D K Ekouévi; Denis Malvy; Philippe Morlat; Michel Dupon; Didier Neau; S Farbos; Catherine Marimoutou; François Dabis
Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(6):1482-7.
2000: F Bonnet; Marianne Savès; C Droz; Evelyne Peuchant; Geneviève Chêne; Jacques Beylot; Philippe Morlat
Increase of atherogenic plasma profile in HIV-infected patients treated with protease inhibitor-containing regimens.
Journal of acquired immune deficiency syndromes (1999) 2000;25(2):199-200.
2000: P L Massoure; Joël Constans; M Caudry; Philippe Morlat; Sophie Skopinski; Jacques Beylot; Maïté Longy-Boursier; Michel Le Bras; C Combe; A Quinton; Jean Saric; Claude Conri
[Upper extremity deep venous thrombosis. 40 hospitalized patients].
Journal des maladies vasculaires 2000;25(4):250-5.
2000: Jean-Michel Molina; Françoise Ferchal; Corinne Rancinan; François Raffi; Willy Rozenbaum; Daniel Sereni; Philippe Morlat; Valérie Journot; JM Decazes; Geneviève Chêne
Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients.
The Journal of infectious diseases 2000;182(2):599-602.
2000: I Delèvaux; Noëlle Bernard; RM Ramanampamonjy; Philippe Morlat; Denis Lacoste; Fabrice Bonnet; C Bonnel; C Deminière; Jacques Beylot
[Multiple medullary and extramedullary plasmacytomas in an HIV infected female patient].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2000;21(7):623-7.
2000: Fabrice Bonnet; Philippe Morlat; Didier Neau; Jean-François Viallard; JM Ragnaud; Michel Dupon; P Legendre; Y Imbert; François Lifermann; Michel Le Bras; Jacques Beylot; Maïté Longy-Boursier
[Hematologic and immunologic manifestations of primary cytomegalovirus infections in non-immunocompromised hospitalized adults].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2000;21(7):586-94.
2000: Charlotte Huët; François Dabis; F Saillour; Pascale Trimoulet; Philippe Morlat; P Rispal; Michel Dupon; C De La Taille; M Partisani; M Bertrand; Jean-Marie Ragnaud; Patrice Couzigou
[Multicenter study of intrafamilial transmission of hepatitis C virus in human immunodeficiency virus infection].
Gastroentérologie clinique et biologique 2000;24(6-7):611-7.
2000: Rodolphe Thiébaut; Philippe Morlat; Hélène Jacqmin-Gadda; Didier Neau; Patrick Mercié; François Dabis; G Chêne
Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d'Epidémiologie du SIDA en Aquitaine (GECSA).
AIDS (London, England) 2000;14(8):971-8.
2000: Remi VATAN; K Delpeu; Christine Vergnes; Joël Constans; Patrick Le-Bougeant; Paquita Nurden; M F Roudaut; Michel René Boisseau; P Le Métayer; Philippe Morlat; Maïté Longy-Boursier; Michel Le Bras; Jacques Beylot; Dominique Midy; Jean-Claude Baste; Claude Conri
[Clinicobiological study of 100 symptomatic patients with factor V Leiden mutation].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2000;21(5):465-6.
2000: F Thiessard; Philippe Morlat; Catherine Marimoutou; E Labouyrie; Jean-Marie Ragnaud; Jean-Luc Pellegrin; Michel Dupon; F Dabis
Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus: Aquitaine Cohort, France, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
Cancer 2000;88(7):1696-702.
2000: Philippe Morlat; Catherine Marimoutou; Laurence Dequae-Merchadou; Isabelle Pellegrin; Patrick Mercié; Didier Neau; Jacques Beylot; François Dabis
Dual nucleoside regimens in nonadvanced HIV infection: prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
Journal of acquired immune deficiency syndromes (1999) 2000;23(3):255-60.
2000: I Delevaux; Noëlle Bernard; Denis Lacoste; C Nouts; Philippe Morlat; Jacques Beylot
[The heart in air].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2000;21(3):297-8.
2000: F Bonnet; Philippe Morlat; I Delevaux; A M Gavinet; Marie Parrens; Noëlle Bernard; Denis Lacoste; Jacques Beylot
A possible association between Chlamydiae psittacci infection and temporal arteritis.
Joint, bone, spine : revue du rhumatisme 2000;67(6):550-2.
1999: Philippe Morlat; G Chêne
[Contribution of clinical epidemiology to the management of HIV infections].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1999;20(8):681-92.
1999: Marianne Savès; Philippe Morlat; Geneviève Chêne; B Dumon; Evelyne Peuchant
Sex differences in HIV-1 viral load and TNF-alpha plasmatic level?
AIDS (London, England) 1999;13(11):1414-5.
1999: Joël Constans; F Sampoux; P Jarnier; P Le Métayer; Dominique Midy; Philippe Morlat; S Bakhach; Maïté Longy-Boursier; Michel Le Bras; Jacques Beylot; Jean-Claude Baste; Claude Conri
[Hemorrhagic complications of antivitamin K. Report of 75 hospitalized patients].
Journal des maladies vasculaires 1999;24(3):202-7.
1999: Noëlle Bernard; R Spira; S Ybanez; Geneviève Chêne; Philippe Morlat; Denis Lacoste; I Loury-Larivière; C Nouts; B Burucoa; M Lebras; Jacques Beylot
Prevalence and underestimation of pain in HIV-infected patients by physicians: a cross-sectional study in a day care hospital.
AIDS (London, England) 1999;13(2):293-5.
1999: Fabrice Bonnet; Patrick Mercié; Philippe Morlat; C Hocke; Christine Vergnes; Emmanuel Ellie; Jean-François Viallard; I Faure; Jean-Luc Pellegrin; Jacques Beylot; Bingfeng Leng
Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus.
Lupus 1999;8(3):244-7.
1998: C Hocke; V Leroy; Philippe Morlat; J Rivel; M C Duluc; N Boulogne; B Tandonnet; M Dupon; Jean-Luc Brun; F Dabis
Cervical dysplasia and human immunodeficiency virus infection in women: prevalence and associated factors. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GESCA).
European journal of obstetrics, gynecology, and reproductive biology 1998;81(1):69-76.
1998: Corinne Rancinan; Philippe Morlat; Geneviève Chêne; Stephane Guez; A Baquey; Jacques Beylot; Roger Salamon
IgE serum level: a prognostic marker for AIDS in HIV-infected adults?
The Journal of allergy and clinical immunology 1998;102(2):329-30.
1998: Geneviève Chêne; Philippe Morlat; Catherine Leport; Richard Hafner; L Dequae; Isabelle Charreau; Jean-Pierre Aboulker; Benjamin J Luft; J Aubertin; Jean-Louis Vildé; Roger Salamon
Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group.
Controlled clinical trials 1998;19(3):233-48.
1997: Sophie Pueyo; L Rachid Salmi; Geneviève Chêne; Catherine Leport; Philippe Morlat; L Dequae; V Grégoire; Richard Hafner; Jean-Louis Vildé; Benjamin J Luft; J Aubertin; Roger Salamon
Survival after AIDS-defining events in patients with < 200 lymphocytes CD4+ x 10(6)/L who are toxoplasmosis antibody positive. ANRS 005/ACTG 154 Trial Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;14(5):459-64.
1997: F Rousseau; Sophie Pueyo; Philippe Morlat; Richard Hafner; G Chène; Catherine Leport; Benjamin J Luft; J Miro; J Aubertin; Roger Salamon; Jean-Louis Vildé
Increased risk of toxoplasmic encephalitis in human immunodeficiency virus-infected patients with pyrimethamine-related rash. ANRS 005-ACTG 154 Trial Group. Agence Nationale de Recherche sur le SIDA (ANRS-INSERM) and the NIAID-AIDS Clinical Trials Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(3):396-402.
1997: Fabrice Bonnet; Patrick Mercié; Philippe Morlat; Hugues Loiseau; François Lifermann; Denis Lacoste; Noëlle Bernard; Claude Vital; Jacques Beylot
[Isolated involvement of the trigeminal nerve of sarcoidosis origin].
Revue neurologique 1997;153(1):59-61.
1997: Corinne Rancinan; Philippe Morlat; Geneviève Chêne; F Saillour; Stephane Guez; Denis Lacoste; Noëlle Bernard; M S Doutre; Claire Sériès; J Aubertin; Jacques Beylot; Roger Salamon
[Prevalence of clinical manifestations of allergic reactions in HIV infection. Cross sectional study of 115 subjects].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1997;18(9):691-4.
1997: Philippe Morlat; C Leport
[Prevention of toxoplasmosis in immunocompromised patients].
Annales de médecine interne 1997;148(3):235-9.
1997: M S Doutre; A Baquey; P Bernard; P Couzigou; N Bernard; Denis Lacoste; Philippe Morlat
[Appearance of antiphospholipid antibodies in patients with hepatitis C treated with interferon-alpha].
Annales de médecine interne 1997;148(1):99-100.
1996: Francis Derouin; Catherine Leport; Sophie Pueyo; Philippe Morlat; B Letrillart; Geneviève Chêne; J L Ecobichon; Benjamin J Luft; J Aubertin; Richard Hafner; Jean-Louis Vildé; Roger Salamon
Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group.
AIDS (London, England) 1996;10(13):1521-7.
1996: Philippe Morlat; Geneviève Chene; J M Ragnaud; Patrick Mercie; F Grobost; Noëlle Bernard; D Lacoste; Jacques Beylot; J Aubertin
Evolution of tumor necrosis factor-alpha serum concentrations in HIV infected individuals treated with zidovudine.
Pathologie-biologie 1996;44(8):716-9.
1996: Philippe Morlat; L Dequae-Merchadou; F Dabis; Geneviève Chene; Roger Salamon; J Beylot
Splenectomy and prognosis of HIV infection. Group d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)
AIDS (London, England) 1996;10(10):1170-2.
1996: Catherine Leport; F Derouin; Philippe Morlat; Geneviève Chene; J L Vildé
[Toxoplasmosis in immunosuppressed patients. Contribution to the knowledge of toxoplasmic infection.].
Médecine et maladies infectieuses 1996;26 Suppl 3():437-40.
1996: J M Ragnaud; A Tahbaz; Philippe Morlat; S Sire; H Gin; J Aubertin
Recurrent aseptic purulent meningitis in a patient with relapsing polychondritis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22(2):374-5.
1996: J Aubertin; Philippe Morlat
[New strategies of vaccination in France in 1995].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1996;17(8):684-8.
1996: Patrick Mercié; Joël Constans; B Tissot; A Sebban; G Gorin; E Rullier; Philippe Morlat; Jacques Beylot; Claude Conri
[Thrombosis of the superior mesenteric artery and Behçet's syndrome].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1996;17(6):470-3.
1996: Patrick Mercié; Philippe Morlat; A N'Gako; P Phéline; M C Bézian; G Gorin; D Lacoste; Noëlle Bernard; I Loury; D Midy; Jean-Claude Baste; Jacques Beylot
[Aortic aneurysms due to Yersinia enterocolitica: three new cases and a review of the literature].
Journal des maladies vasculaires 1996;21(2):68-71.
1996: Philippe Morlat; C Bartou; J M Ragnaud; L Dequae; D Lacoste; M Buisson; Noëlle Bernard; Patrick Mercié; B Couprie; Jacques Beylot; J Aubertin
[Pneumocystis carinii pneumonia in AIDS: retrospective analysis of 80 documented cases (1985-1993)].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1996;17(1):25-33.
1996: Catherine Leport; Geneviève Chêne; Philippe Morlat; Benjamin J Luft; F Rousseau; Sophie Pueyo; Richard Hafner; J Miro; J Aubertin; Roger Salamon; Jean-Louis Vildé
Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group.
The Journal of infectious diseases 1996;173(1):91-7.
1995: C Hocke; Philippe Morlat; Geneviève Chene; L Dequae; F Dabis
Prospective cohort study of the effect of pregnancy on the progression of human immunodeficiency virus infection. The Groupe d'Epidémiologie Clinique Du SIDA en Aquitaine.
Obstetrics and gynecology 1995;86(6):886-91.
1995: Bernard Masquelier; Isabelle Pellegrin; Annick Ruffault; Jean-Marie Ragnaud; Philippe Morlat; Christian Michelet; François DOIGNON; N Biteau; H J Fleury
Genotypic evolution of HIV-1 isolates from patients after a switch of therapy from zidovudine to didanosine.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;8(4):330-4.
1995: Patrick Mercié; Philippe Morlat; G Gorin; Noëlle Bernard; D Lacoste; Jacques Beylot
[A medio-protuberant hypersignal].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1995;16(11):864.
1995: Philippe Morlat; J B Hubert; Geneviève Chêne; M Buisson; M C Paty; Catherine Lasseur; Joël Constans; Noëlle Bernard; Jacques Beylot
[Effect of primary prevention of Pneumocystis carinii pneumonia on the inaugural clinical and biological presentation of AIDS: 624 cases (Aquitaine Cohort, 1985-1994)].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1995;16(11):815-7.
1995: N Bernard; D Lacoste; F Lifermann; Philippe Morlat; Eric Labouyrie; A Broustet; Jacques Beylot
[Multiple splenic abscesses in a 42-year-old man. Uncommon manifestation of myeloma].
Annales de médecine interne 1995;146(5):337-8.
1995: Catherine Lasseur; Jeanne Maugein; Jean-Luc Pellegrin; Michel Dupon; J M Ragnaud; Philippe Morlat; Isabelle Pellegrin; Joël Constans; E Monlun; Geneviève Chene
[Disseminated Mycobacterium avium complex infections in AIDS. Apropos of 100 cases. Groupe d'Epidémiologie clinique du SIDA en Aquitaine].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1995;16(2):110-20.
1995: F Lifermann; A Lescure; N Bernard; D Lacoste; Philippe Morlat; Jacques Beylot
[Intra-alveolar hemorrhages disclosing Wegener disease with hepatic involvement].
Annales de médecine interne 1995;146(3):211.
1995: T Mayet; D Lacoste; Philippe Morlat; F Lifermann; N Bernard; G A Boffa; G Brun; Jacques Beylot; A De Mascarel
[Polycythemia secondary to pelvic leiomyosarcoma. Apropos of a case].
Annales de médecine interne 1995;146(2):134-5.
1995: J M Ragnaud; Philippe Morlat; M Buisson; X Ferrer; J M Orgogozo; J Julien; Jacques Beylot; J Aubertin
[Neurologic manifestations of Lyme disease. Apropos of 25 cases].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1995;16(7):487-94.
1994: J M Ragnaud; Philippe Morlat; Henri Gin; M Dupon; C Delafaye; P du Pasquier; J Aubertin
[Clinical, biological and developmental aspects of cytomegalovirus infection in immunocompetent patients: apropos of 34 hospitalized patients].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1994;15(1):13-8.
1994: J M Ragnaud; Philippe Morlat; M Buisson; Maïté Longy-Boursier; E Monlun; C Wone; M Lebras; Jacques Beylot; J Aubertin
[Epidemiological, clinical, biological and developmental aspects of leptospirosis: apropos of 30 cases in Aquitaine].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1994;15(7):452-9.
1994: N Bernard; F Cordet; F Lifermann; D Lacoste; Philippe Morlat; J Reiffers; Jacques Beylot
[Malabsorption syndrome caused by digestive amyloidosis. Uncommon manifestation of light chain myeloma in a 38-year-old woman].
Annales de médecine interne 1994;145(7):504-5.
1993: J M Ragnaud; Philippe Morlat; Michel Dupon; D Lacoste; Jean-Luc Pellegrin; Geneviève Chene
[Cerebral toxoplasmosis in AIDS. 73 cases. Clinical Epidemiology Group on AIDS in Aquitania].
Presse médicale (Paris, France : 1983) 1993;22(19):903-8.
1993: J M Ragnaud; Philippe Morlat; X Ferrer; J M Orgogozo; J Julien; Jacques Beylot; J Aubertin
[Neurologic manifestations in Lyme disease. Apropos of 22 cases].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1993;14(10):985.
1993: Philippe Morlat; Geneviève Chene; Catherine Leport; F Rousseau; Benjamin J Luft; J Aubertin; Richard Hafner; Roger Salamon; J L Vilde
[Primary prevention of cerebral toxoplasmosis in patients with HIV infection: results of a double-blind randomized trial, pyrimethamine versus placebo].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1993;14(10):1002.
1993: Sophie Pueyo; Catherine Leport; Geneviève Chene; Philippe Morlat; Richard Hafner; J L Vilde; Benjamin J Luft; Roger Salamon; J Aubertin
[Risk factors of cerebral toxoplasmosis in patients with HIV infection: data of a primary prevention trial].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1993;14(10):1001.
1993: Philippe Morlat; C Hocke; Geneviève Chene; Catherine Lasseur; Michel Dupon; E Monlun; F Bonnal; Joël Constans; D Lacoste; J M Ragnaud
[Prognostic role of pregnancy on the course of HIV infection: a retrospective cohort study (1985-92)].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1993;14(10):1000.
1992: M Hajjar; D Lacoste; G Brossard; Philippe Morlat; M Dupon; L Rachid Salmi; F Dabis
Non-acquired immune deficiency syndrome-defining malignancies in a hospital-based cohort of human immunodeficiency virus-infected patients: Bordeaux, France, 1985-1991. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
Journal of the National Cancer Institute 1992;84(20):1593-5.
1992: Philippe Morlat; P Parneix; D Douard; Denis Lacoste; Michel Dupon; Geneviève Chêne; Jean-Luc Pellegrin; Jean-Marie Ragnaud; François Dabis
Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. The Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
AIDS (London, England) 1992;6(10):1187-93.
1992: J Ladner; G Brossard; F Dabis; Philippe Morlat; Anne-Marie Rogues
[Seroprevalence of viral hepatitis C in patients with human immunodeficiency virus infection].
Presse médicale (Paris, France : 1983) 1992;21(5):219.
1991: Philippe Morlat; G Chène; J M Ragnaud; D Lacoste; M Dupon; J L Pellegrin
[Main epidemiological characteristics of esophageal candidiasis in AIDS (Bordeaux, France 1985-1990. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)].
Presse médicale (Paris, France : 1983) 1991;20(44):2265.
1991: Philippe Morlat; G Checkouri; J M Ragnaud; M Dupon; G Brossard; D Lacoste
[Importance of heterosexual contamination in human immunodeficiency virus infection (Bordeaux, 1985-1990)].
Presse médicale (Paris, France : 1983) 1991;20(2):83.
1989: Philippe Morlat; B Duthil; H Gin; J M Ragnaud; J Aubertin; C Bebear
[Actinobacillus ureae meningitis. Apropos of a case].
Pathologie-biologie 1989;37(10):1099-101.
1989: Henri Gin; R Viala; F Rigal; Philippe Morlat; J M Beauvieux; J Aubertin
[Panic attack caused by biguanides].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1989;10(4):361-3.
1989: J M Ragnaud; Michel Dupon; Philippe Morlat; M C Bezian; C Wone
[Treatment of peritonitis under continuous ambulatory peritoneal dialysis using intraperitoneal ceftazidime].
Pathologie-biologie 1989;37(5 Pt 2):681-4.
1988: Henri Gin; I Lars; J M Beauvieux; Philippe Morlat; J Aubertin
[Hyponatremia induced by biguanides. Case report].
Presse médicale (Paris, France : 1983) 1988;17(12):591.
1988: Henri Gin; I Lars; Philippe Morlat; J M Beauvieux; J Aubertin
[Hyponatremia induced by hypoglycemic sulfonamides: a study of 70 patients].
Annales de médecine interne 1988;139(7):455-9.